| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/21/2008 | CN101184488A Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
| 05/21/2008 | CN101184481A Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury |
| 05/21/2008 | CN101182355A Antibacterial peptide fusion protein gene, recombinant carrier thereof, transformant and expression product thereof |
| 05/21/2008 | CN101181600A Traditional chinese medicine composition for curing cardiovascular and cerebrovascular diseases |
| 05/21/2008 | CN101181581A Shallot extract as well as preparation method and usage thereof |
| 05/21/2008 | CN101181551A Externally used unction for curing hemorrhoid |
| 05/21/2008 | CN101181533A Chinese traditional medicine for curing brain angiocardiopathy |
| 05/21/2008 | CN101181520A Chinese traditional medicine tonic wine for tonifying kidney and nourishing blood |
| 05/21/2008 | CN101181519A Hongxue Tea particle for curing hypertension and hyperlipemia |
| 05/21/2008 | CN101181518A Baoxin pill for curing coronary disease |
| 05/21/2008 | CN101181505A Chinese medicine prescription for cardiac disease as well as manufacturing method |
| 05/21/2008 | CN101181498A Chinese medicine prescription for reducing blood pressure as well as manufacturing method |
| 05/21/2008 | CN101181483A Chinese patent drug for curing cataptosis and hemiparalysis sequela |
| 05/21/2008 | CN101181477A Chinese medicine specific for curing hemorrhoid and manufacturing method thereof |
| 05/21/2008 | CN101181476A External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
| 05/21/2008 | CN101181450A Cataptosis rescue powder |
| 05/21/2008 | CN101181445A Antihypertensive Chinese medicine |
| 05/21/2008 | CN101181444A Multi-efficacy externally used drug as well as method for preparing immersion agent thereof |
| 05/21/2008 | CN101181434A Chinese medicine composition orally taken for curing hemorrhoid |
| 05/21/2008 | CN101181418A Medicine composition for curing arrhythmia and preparation method thereof |
| 05/21/2008 | CN101181387A Whitethorn leaf total chromocor colloidal solution and preparation method thereof |
| 05/21/2008 | CN101181383A Medicine composition for treating apoplexy as well as preparation method |
| 05/21/2008 | CN101181373A Cortex moutan valid target pharmaceutical combination, preparation method and application thereof |
| 05/21/2008 | CN101181354A Fructus schizandrae chemical composition group extract and preparation technique |
| 05/21/2008 | CN101181350A Technique for preparing fufang danshen pian |
| 05/21/2008 | CN101181333A Chinese medicine injection for curing cardiovascular and cerebrovascular diseases as well as method for manufacture and mass control thereof |
| 05/21/2008 | CN101181327A Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof |
| 05/21/2008 | CN101181324A Medication new purpose of panax notoginsenoside injection |
| 05/21/2008 | CN101181322A Composition of ligustrazine and acanthopanax senticosus concrete as well as application in the preparation of anti-cardiovascular medicament thereof |
| 05/21/2008 | CN101181318A Shanlu Tea extract for dropping blood pressure and blood fat as well as preparation method thereof |
| 05/21/2008 | CN101181315A New purpose of Yulangsan polysaccharide |
| 05/21/2008 | CN101181313A Application of compound composition in the preparation of cardiovascular and cerebrovascular diseases medicament |
| 05/21/2008 | CN101181308A New purpose of married rat and pharmaceutical composition for curing hemorrhoid |
| 05/21/2008 | CN101181293A Oral health lozenge for preventing tooth decay |
| 05/21/2008 | CN101181292A Tea polyoses oral liquid |
| 05/21/2008 | CN101181291A Tea polyoses injection |
| 05/21/2008 | CN101181283A Ant-ihemorrhoid pharmaceutical combination |
| 05/21/2008 | CN101181282A Hydroxyl radical carthamin yellow carthamus A soft capsule with high bioavailability and preparation method thereof |
| 05/21/2008 | CN101181259A Sustained-release agent of nitric acid dinitrate and preparation method thereof |
| 05/21/2008 | CN101181256A Drug complexes for preventing and curing schemic cerebrovaseular disease as well as preparation method thereof |
| 05/21/2008 | CN101181254A Slimming appetising capsule containing natural capsicine for promoting blood circulation and reducing blood fat |
| 05/21/2008 | CN101181243A Adenosine cyclophosphate freeze-dry preparations and preparation method thereof |
| 05/21/2008 | CN100389126C Endothelial cell proliferation inhibitor and method of use |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100388950C Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction |
| 05/21/2008 | CN100388938C Capsule for treating diabetic coronary heart disease |
| 05/21/2008 | CN100388927C Medicine for treating apoplexy and its preparing process |
| 05/20/2008 | US7375252 Compounds and method for the inhibition of the expression of VCAM-1 |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375227 May be combined with ACE inhibitors, angiotensin or endothelin receptor antagonists, vasopressin antagonists, alpha- and beta-adrenergic antagonists, TNFalpha antagonists, and peroxisome proliferator activator receptor modulators; cardiovascular, renal, metabolic, pulmonary and psychological disorders |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375135 Fatty acid derivatives; preparation and uses thereof |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375103 (-)-7-[2-(cyclopropylmethoxy)-6-hydroxyphenyl]-5-[(3S)-3-piperidinyl]-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one or salt as I kappa-B kinase inhibitor; antiinflammatory agent; autoimmune diseases, ischemia, cancer |
| 05/20/2008 | US7375087 prevention or treatment of disease associated with hyperglycemia: diabetes, impaired glucose tolerance, impaired fasting glycemia, diabetic complications or obesity; e.g. 4-[(4-{3-[1-carbamoyl-1-(methyl)-ethylcarbamoyl]propyl}-2-methylphenyl)methyl]-3-( beta -D-glucopyranosyloxy)-5-isopropyl-1H-pyrazole |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/20/2008 | CA2385440C 5-hydroxysapogenin derivatives with anti-dementia activity |
| 05/20/2008 | CA2359008C Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 05/20/2008 | CA2317465C Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same |
| 05/20/2008 | CA2268886C Aminothiophenecarboxamides |
| 05/20/2008 | CA2231971C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/20/2008 | CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them |
| 05/20/2008 | CA2169694C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/15/2008 | WO2008057497A2 Small organic molecule regulators of cell proliferation |
| 05/15/2008 | WO2008056726A1 Glp-1 derivative and use thereof |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008056634A1 Novel hydroxyindole derivative |
| 05/15/2008 | WO2008056450A1 Blood neutral fat level-lowering agent, hdl cholesterol level-increasing agent, and arterial stiffness index-lowering agent |
| 05/15/2008 | WO2008056176A1 Pyrazolopyrimidines as phosphodiesterase inhibitors |
| 05/15/2008 | WO2008055669A1 Salt of aliskiren with orotic acid |
| 05/15/2008 | WO2008055310A1 Process for the preparation of angiogenin |
| 05/15/2008 | WO2008035359A3 Oximinophenoxyalkanoic acid and phenylalkanoic acid derivatives |
| 05/15/2008 | WO2007144768A3 Use of peptidic vasopressin receptor agonists |
| 05/15/2008 | WO2007092270B1 Combination therapy for coronary artery disease |
| 05/15/2008 | US20080114285 Energy-activated targeted cancer therapy |
| 05/15/2008 | US20080114187 Formoterol tartrate process and polymorph |
| 05/15/2008 | US20080114079 TRPM2-specfic inhibitors |
| 05/15/2008 | US20080114074 Phytoene and/or phytofluene |
| 05/15/2008 | US20080114059 Novel Compounds For Treatment of Cardiac Arrhythmia and Methods of Use |
| 05/15/2008 | US20080114051 Pyrrolidine derivatives as prostaglandin modulators |
| 05/15/2008 | US20080114044 Isoxazole compounds as Peroxisome Proliferator-Activated Receptor (PPAR) delta modulators; (5-{4-[2-(2,4-Dichloro-phenoxy)-ethyl-carbamoyl]-5-phenyl-isoxazol-3-yl}-phenyl)-acetic acid; diabetes, cardiovascular disorders, dyslipidemias, irritable bowel disease, cancer, skin disorders, eye disorders |
| 05/15/2008 | US20080114042 Compound |
| 05/15/2008 | US20080114034 ethyl 1-benzyl-5-(3-carboxypropoxy)-2-methyl-6-pyrid-3-yl-1H-indole-3-carboxylate; peroxisome proliferator activated receptors agonist; dyslipidaemia, atherosclerosis, diabetes, obesity; high level lipoprotein controllong |
| 05/15/2008 | US20080114031 1,2;5,6-Di-O-isopropylidene-3-deoxy-3-[{(4-chloro-phenyl)amino}-carbonyl]-amino- alpha -D-allofuranoside; |
| 05/15/2008 | US20080114018 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 05/15/2008 | US20080114007 8-indan-5-yl-5-oxo-2-(3-piperazin-1-yl-phenylamino)-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid isopropylamide; antiinflammatory, anticarcinogenic agent, cardiovascular disease; glomerulonephritis, immune nephritis, rheumatoid arthritis, asthma, pancreatitis, HIV infection, psoriasis |
| 05/15/2008 | US20080114006 For example, 1-(5-(2-amino-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)-2-fluorophenyl)-3-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)urea; for treatment of mammalian cancers and inflammatory diseases including rheumatoid arthritis, retinopathies |
| 05/15/2008 | US20080114003 Pyrimidinylisoxazole Derivatives |
| 05/15/2008 | US20080114000 Suppressor of excess accumulation of intracellular sodium ions |
| 05/15/2008 | US20080113997 Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 05/15/2008 | US20080113993 Barbituric acid analogs as therapeutic agents |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113982 Azacyclosteroid histamine-3 receptor ligands |
| 05/15/2008 | US20080113977 For example, 7-Bromo-4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline; for treating physiological disorders, particularly congestive heart disease |